239 related articles for article (PubMed ID: 28185416)
1. Anti-HMGCR autoantibodies in self-limiting statin-induced myopathy.
Keating P; Young J; George P; Florkowski C; Spellerberg M; Kennedy N
Int J Rheum Dis; 2017 Dec; 20(12):2179-2181. PubMed ID: 28185416
[No Abstract] [Full Text] [Related]
2. Patient with statin-associated immune-mediated necrotizing myopathy presenting with subcutaneous edema, persistent bulbar weakness and absent anti-HMGCR.
Ong SG; Ding HJ
Int J Rheum Dis; 2017 Dec; 20(12):2175-2178. PubMed ID: 26692320
[No Abstract] [Full Text] [Related]
3. Identifying statin-associated autoimmune necrotizing myopathy.
Albayda J; Christopher-Stine L
Cleve Clin J Med; 2014 Dec; 81(12):736-41. PubMed ID: 25452351
[TBL] [Abstract][Full Text] [Related]
4. Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure.
Shovman O; Gilburd B; Chayat C; Lazar AD; Amital H; Blank M; Bentow C; Mahler M; Shoenfeld Y
Immunol Res; 2017 Feb; 65(1):276-281. PubMed ID: 27618830
[TBL] [Abstract][Full Text] [Related]
5. Statin-Induced Anti-HMGCR-Associated Myopathy.
Basharat P; Lahouti AH; Paik JJ; Albayda J; Pinal-Fernandez I; Bichile T; Lloyd TE; Danoff SK; Casciola-Rosen L; Mammen AL; Christopher-Stine L
J Am Coll Cardiol; 2016 Jul; 68(2):234-5. PubMed ID: 27386780
[No Abstract] [Full Text] [Related]
6. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies].
Merlant M; Fite C; Kottler D; Maisonobe L; Dossier A; Deschamps L; Descamps V
Ann Dermatol Venereol; 2019 Sep; 146(8-9):550-556. PubMed ID: 30929872
[TBL] [Abstract][Full Text] [Related]
7. Anti-HMGCR antibody-associated necrotizing myopathy: diagnosis and treatment illustrated using a case report.
Giudizi MG; Cammelli D; Vivarelli E; Biagiotti R; Ferraro A; Bentow C; Almerigogna F; Albesa R; Mahler M
Scand J Rheumatol; 2016 Oct; 45(5):427-9. PubMed ID: 26886059
[No Abstract] [Full Text] [Related]
8. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J
J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
[TBL] [Abstract][Full Text] [Related]
9. Clinico-serologic features of statin-induced necrotising autoimmune myopathy in a single-centre cohort.
Waters MJ; Limaye V
Clin Rheumatol; 2018 Feb; 37(2):543-547. PubMed ID: 28905130
[TBL] [Abstract][Full Text] [Related]
10. Immune-mediated necrotizing myopathy due to statins exposure.
Villa L; Lerario A; Calloni S; Peverelli L; Matinato C; DE Liso F; Ceriotti F; Tironi R; Sciacco M; Moggio M; Triulzi F; Cinnante C
Acta Myol; 2018 Dec; 37(4):257-262. PubMed ID: 30944904
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy.
Mammen AL; Chung T; Christopher-Stine L; Rosen P; Rosen A; Doering KR; Casciola-Rosen LA
Arthritis Rheum; 2011 Mar; 63(3):713-21. PubMed ID: 21360500
[TBL] [Abstract][Full Text] [Related]
12. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.
Werner JL; Christopher-Stine L; Ghazarian SR; Pak KS; Kus JE; Daya NR; Lloyd TE; Mammen AL
Arthritis Rheum; 2012 Dec; 64(12):4087-93. PubMed ID: 22933019
[TBL] [Abstract][Full Text] [Related]
13. Absence of anti-HMG-CoA reductase autoantibodies in severe self-limited statin-related myopathy.
Floyd JS; Brody JA; Tiniakou E; Psaty BM; Mammen A
Muscle Nerve; 2016 Jun; 54(1):142-4. PubMed ID: 27038110
[TBL] [Abstract][Full Text] [Related]
14. Proposed cut-off for reactivity of anti-HMGCR and anti-SRP antibodies in patients statin-exposed and statin-unexposed.
Carvalho AAS; Silva VGD; Vieira TF; Delgado PO; Corazini R; Feder D; Fonseca FLA
Medicine (Baltimore); 2018 Aug; 97(35):e11858. PubMed ID: 30170376
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune myopathy due to statin treatment in an elderly woman.
Nicolas B; Berthier S; Sordet-Guépet H; Aubriot-Lorton MH; Manckoundia P
J Am Geriatr Soc; 2014 May; 62(5):991-2. PubMed ID: 24828936
[No Abstract] [Full Text] [Related]
16. Anti-HMGCR Myopathy.
Mohassel P; Mammen AL
J Neuromuscul Dis; 2018; 5(1):11-20. PubMed ID: 29480216
[TBL] [Abstract][Full Text] [Related]
17. Anti-HMGCR Antibody-Related Necrotizing Autoimmune Myopathy Mimicking Muscular Dystrophy.
Tard C; Tiffreau V; Jaillette E; Jouen F; Nelson I; Bonne G; Yaou RB; Romero N; Vallée L; Vermersch P; Nguyen S; Maurage CA; Cuisset JM
Neuropediatrics; 2017 Dec; 48(6):473-476. PubMed ID: 28778101
[No Abstract] [Full Text] [Related]
18. Mushroom supplements triggering a flare of HMGCR immune mediated necrotising myopathy.
Adler B; Christopher-Stine L; Tiniakou E
BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35606030
[TBL] [Abstract][Full Text] [Related]
19. Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects.
Mammen AL; Pak K; Williams EK; Brisson D; Coresh J; Selvin E; Gaudet D
Arthritis Care Res (Hoboken); 2012 Feb; 64(2):269-72. PubMed ID: 21972203
[TBL] [Abstract][Full Text] [Related]
20. When Statins Cause an Autoimmune Response: A Report of a Severe Case of Rhabdomyolysis.
Hasan S; Abushahin A; Prayson R; Kilani A
Am J Med; 2020 Jan; 133(1):50-51. PubMed ID: 31247184
[No Abstract] [Full Text] [Related]
[Next] [New Search]
